ANSX-98

N/A

Report date: 2025/01/26 19:13:29
NME

Base Information

Drug NameANSX-98
Drug Alias NameANSX-98
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCystitisLeukoencephalopathy, Progressive Multifocal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnsun Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnsun Biopharma Inc
Inactive CompaniesN/A
Active IndicationsCystitisLeukoencephalopathy, Progressive Multifocal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A